Appendix Table A
Association between blood lead and systolic and diastolic blood pressure, by age group and sex, household population aged 40 to 79, Canada, 2007 to 2011
| Model, age group and sex | Systolic blood pressure | Diastolic blood pressure | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Unadjusted | AdjustedNote † | Unadjusted | AdjustedNote † | |||||||||||||
| Beta | 95% confidence interval | p-value | Beta | 95% confidence interval | p-value | Beta | 95% confidence interval | p-value | Beta | 95% confidence interval | p-value | |||||
| from | to | from | to | from | to | from | to | |||||||||
| Model 1. Aged 40 to 79 | ||||||||||||||||
| Blood lead linear (µg/dL) | 5.17Note * | 2.89 | 7.45 | 0.000 | 1.85 | -0.20 | 3.90 | 0.075 | 1.83Note * | 0.60 | 3.07 | 0.005 | 1.91Note * | 0.75 | 3.08 | 0.002 |
| Blood lead restricted cubic spline | -0.49Note * | -0.78 | -0.19 | 0.003 | -0.15 | -0.40 | 0.09 | 0.208 | -0.18Note * | -0.32 | -0.05 | 0.011 | -0.19Note * | -0.33 | -0.06 | 0.006 |
| Model 1a. Untreated for hypertensionNote ‡ | ||||||||||||||||
| Blood lead linear (µg/dL) | 5.22Note * | 2.82 | 7.63 | 0.000 | 1.50 | -1.00 | 4.00 | 0.227 | 2.69Note * | 1.17 | 4.22 | 0.001 | 1.99Note * | 0.42 | 3.56 | 0.015 |
| Blood lead restricted cubic spline | -0.53Note * | -0.82 | -0.24 | 0.001 | -0.16 | -0.44 | 0.13 | 0.266 | -0.28Note * | -0.46 | -0.10 | 0.004 | -0.21Note * | -0.39 | -0.02 | 0.031 |
| Model 2. Aged 40 to 54 | ||||||||||||||||
| Blood lead linear (µg/dL) | 3.75Note * | 1.43 | 6.07 | 0.003 | 2.63Note * | -0.03 | 5.29 | 0.052 | 3.15Note * | 1.33 | 4.97 | 0.002 | 2.28Note * | 0.31 | 4.26 | 0.025 |
| Blood lead restricted cubic spline | -0.42Note * | -0.74 | -0.10 | 0.012 | -0.31Note * | -0.62 | 0.00 | 0.053 | -0.37Note * | -0.61 | -0.13 | 0.004 | -0.29Note * | -0.54 | -0.03 | 0.029 |
| Model 2a. Untreated for hypertensionNote ‡ | ||||||||||||||||
| Blood lead linear (µg/dL) | 4.45Note * | 1.95 | 6.95 | 0.001 | 2.80 | -0.40 | 6.00 | 0.084 | 3.80Note * | 2.02 | 5.59 | 0.000 | 2.83Note * | 0.59 | 5.08 | 0.016 |
| Blood lead restricted cubic spline | -0.51Note * | -0.84 | -0.17 | 0.005 | -0.33 | -0.69 | 0.04 | 0.076 | -0.44Note * | -0.67 | -0.21 | 0.001 | -0.33Note * | -0.61 | -0.06 | 0.019 |
| Model 3. Aged 55 to 79 | ||||||||||||||||
| Blood lead linear (µg/dL) | 1.51 | -1.76 | 4.77 | 0.350 | 0.86 | -2.41 | 4.12 | 0.593 | 1.41 | -0.54 | 3.37 | 0.149 | 1.07 | -0.73 | 2.87 | 0.230 |
| Blood lead restricted cubic spline | -0.07 | -0.47 | 0.34 | 0.736 | 0.00 | -0.39 | 0.39 | 0.991 | -0.11 | -0.34 | 0.11 | 0.308 | -0.08 | -0.28 | 0.12 | 0.441 |
| Model 3a. Untreated for hypertensionNote ‡ | ||||||||||||||||
| Blood lead linear (µg/dL) | 0.50 | -2.90 | 3.91 | 0.763 | 0.04 | -3.43 | 3.50 | 0.983 | 0.93 | -1.77 | 3.63 | 0.484 | 0.35 | -2.05 | 2.75 | 0.766 |
| Blood lead restricted cubic spline | 0.00 | -0.41 | 0.41 | 0.994 | 0.04 | -0.37 | 0.45 | 0.835 | -0.06 | -0.37 | 0.25 | 0.700 | 0.00 | -0.28 | 0.28 | 0.991 |
| Model 4. Men aged 40 to 79 | ||||||||||||||||
| Blood lead linear (µg/dL) | 4.02Note * | 1.54 | 6.50 | 0.003 | 2.17 | -0.08 | 4.42 | 0.058 | 0.88 | -0.53 | 2.30 | 0.210 | 2.36Note * | 0.94 | 3.79 | 0.002 |
| Blood lead restricted cubic spline | -0.39Note * | -0.68 | -0.10 | 0.010 | -0.21 | -0.46 | 0.04 | 0.090 | -0.10 | -0.25 | 0.05 | 0.191 | -0.25Note * | -0.40 | -0.10 | 0.002 |
| Model 4a. Untreated for hypertensionNote ‡ | ||||||||||||||||
| Blood lead linear (µg/dL) | 2.94 | -0.27 | 6.16 | 0.071 | 0.85 | -1.86 | 3.56 | 0.522 | 1.75Note * | 0.20 | 3.30 | 0.029 | 2.46Note * | 0.95 | 3.98 | 0.003 |
| Blood lead restricted cubic spline | -0.29 | -0.69 | 0.10 | 0.138 | -0.07 | -0.40 | 0.26 | 0.654 | -0.20Note * | -0.37 | -0.02 | 0.034 | -0.25Note * | -0.44 | -0.07 | 0.010 |
| Model 5. Women aged 40 to 79 | ||||||||||||||||
| Blood lead linear (µg/dL) | 5.25Note * | 1.48 | 9.03 | 0.008 | 0.76 | -2.72 | 4.24 | 0.656 | 0.98 | -1.00 | 2.95 | 0.319 | 1.43 | -0.51 | 3.38 | 0.142 |
| Blood lead restricted cubic spline | -0.42 | -1.05 | 0.20 | 0.176 | 0.02 | -0.55 | 0.59 | 0.935 | -0.08 | -0.34 | 0.18 | 0.528 | -0.12 | -0.37 | 0.12 | 0.313 |
| Model 5a. Untreated for hypertensionNote ‡ | ||||||||||||||||
| Blood lead linear (µg/dL) | 5.53Note * | 2.01 | 9.04 | 0.003 | 1.88 | -1.89 | 5.65 | 0.314 | 1.39 | -1.07 | 3.85 | 0.253 | 1.66 | -0.97 | 4.29 | 0.205 |
| Blood lead restricted cubic spline | -0.56Note * | -1.11 | -0.01 | 0.046 | -0.22 | -0.76 | 0.32 | 0.403 | -0.14 | -0.50 | 0.22 | 0.427 | -0.17 | -0.52 | 0.18 | 0.336 |
Source: 2007 to 2009 and 2009 to 2011 Canadian Health Measures Survey, combined. |
||||||||||||||||
- Date modified: